Abdel-Maksoud Nashwa H M, El-Shamy Ahmed, Fawzy Mohamed, Gomaa Hanaa H A, Eltarabilli Mokhtar M A
Faculty of Science, Department of Botany, Suez Canal University, Ismailia, Egypt.
Department of Pharmaceutical and Biomedical Sciences, Collage of Pharmacy, Department of Basic Sciences, College of Medicine, California Northstate University, Elk Grove, CA, USA.
Microbiol Immunol. 2019 Feb;63(2):77-84. doi: 10.1111/1348-0421.12670.
Hepatitis B virus (HBV) infection is a serious nosocomial infection that affects patients undergoing hemodialysis (HD). However, certain HBV variants are not detected by routine serological tests in Egyptian dialysis units because of mutations that change important viral antigens (Ags). Of note, these mutations can result in the appearance of different HBV variants with different clinical manifestations. Thus, the present study aimed to assess different clinical forms of HBV infections and viral genotypes among patients undergoing HD in the Ismailia governorate of Egypt. To this end, serum samples were collected from 150 patients undergoing HD and screened for HBV-DNA using a nested PCR technique. Positive samples were then screened for HBV serological markers (hepatitis B core antibody [HBcAb], hepatitis B surface antigen, hepatitis B surface antibody, hepatitis B e antigen and hepatitis B e antibody) using ELISA and the HBV viral load quantitated by qPCR. HBV genotypes were detected by direct sequencing of the partial surface (S) gene. The most common clinical form of HBV infection in our study cohort was overt HBV infection (10%); followed by seropositive occult hepatitis B infection (7.3%), most of whom had an isolated HBcAb. The least common form was the precore mutant (1.3%). All HBV isolates were genotype D. This study reveals the importance of HBcAb and PCR in screening for HBV, especially for detection of occult hepatitis B infection.
乙型肝炎病毒(HBV)感染是一种严重的医院感染,会影响接受血液透析(HD)的患者。然而,由于改变重要病毒抗原(Ag)的突变,埃及透析单位的常规血清学检测无法检测到某些HBV变异体。值得注意的是,这些突变可导致出现具有不同临床表现的不同HBV变异体。因此,本研究旨在评估埃及伊斯梅利亚省接受HD治疗的患者中HBV感染的不同临床形式和病毒基因型。为此,收集了150例接受HD治疗的患者的血清样本,并使用巢式PCR技术筛查HBV-DNA。然后使用ELISA对阳性样本进行HBV血清学标志物(乙肝核心抗体[HBcAb]、乙肝表面抗原、乙肝表面抗体、乙肝e抗原和乙肝e抗体)筛查,并通过qPCR对HBV病毒载量进行定量。通过对部分表面(S)基因进行直接测序来检测HBV基因型。在我们的研究队列中,HBV感染最常见的临床形式是显性HBV感染(10%);其次是血清学阳性隐匿性乙型肝炎感染(7.3%),其中大多数人仅有HBcAb。最不常见的形式是前核心突变体(1.3%)。所有HBV分离株均为D基因型。本研究揭示了HBcAb和PCR在筛查HBV中的重要性,尤其是在检测隐匿性乙型肝炎感染方面。